SERPINB1 and diabetes mellitus: Subjects with diabetes often exhibit hyperinsulinemia, glucagon dysregulation, hyperglycemia-induced microinflammation, oxidative stress, endoplasmic reticulum (ER) stress, and/or dyslipidemia, which might regulate the SerpinB1 expression via hepatic regulation of FoxO1.